Simplex Trading
FULC icon

Simplex Trading’s Fulcrum Therapeutics FULC Stock Holding History

Simplex Trading’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$234K Buy
30,500
+15,600
+105% +$145K ﹤0.01% 4118
2025
Q4 		$169K Buy
+14,900
New +$152K ﹤0.01% 4407
2025
Q1 		– Sell
-9,900
Closed -$46K – 8860
2024
Q4 		$46K Sell
9,900
-187,600
-95% -$692K ﹤0.01% 5962
2024
Q3 		$705K Buy
197,500
+194,000
+5,543% +$1.44M ﹤0.01% 3248
2024
Q2 		$21K Buy
3,500
+2,500
+250% +$18.9K ﹤0.01% 6850
2024
Q1 		$9K Buy
+1,000
New +$8.93K ﹤0.01% 7671
2023
Q4 		– Sell
-89,700
Closed -$398K – 9135
2023
Q3 		$398K Buy
89,700
+76,500
+580% +$334K ﹤0.01% 3644
2023
Q2 		$43K Buy
13,200
+11,200
+560% +$32.9K ﹤0.01% 5989
2023
Q1 		$5K Sell
2,000
-5,600
-74% -$50.2K ﹤0.01% 8037
2022
Q4 		$55K Buy
7,600
+2,300
+43% +$15K ﹤0.01% 5753
2022
Q3 		$42K Buy
5,300
+2,700
+104% +$19.3K ﹤0.01% 6671
2022
Q2 		$12K Sell
2,600
-16,100
-86% -$157K ﹤0.01% 8119
2022
Q1 		$442K Buy
18,700
+17,900
+2,238% +$253K ﹤0.01% 3990
2021
Q4 		$14K Buy
+800
New +$15.8K ﹤0.01% 8741

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Simplex Trading's FULC Position: Q1 2026 in Review

Simplex Trading increased its Fulcrum Therapeutics (FULC) stake by 423% in Q1 2026, buying an estimated $315K and bringing the position to 41,940 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #3749.

Simplex Trading first reported a position in FULC in Q1 2022 and has held it in 14 quarters since. The position peaked at $752K in Q2 2025. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Simplex Trading held 41,940 shares of Fulcrum Therapeutics worth $322K as of Q1 2026.
  • Simplex Trading bought 33,926 Fulcrum Therapeutics shares in Q1 2026, an estimated $315K.
  • Fulcrum Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3749 holding.
  • Simplex Trading first reported a position in Fulcrum Therapeutics in Q1 2022 and has held it in 14 quarters since.
  • Simplex Trading's Fulcrum Therapeutics position peaked at $752K in Q2 2025.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.